Immunoprecise Antibodies Ltd.
13F holders, Q4 2024 (December 31)19holders +1
1new positions
0sold out
1famous investor
$0.41avg. 13F price*
At the end of Q4 2024, 19 institutions reported holding Immunoprecise Antibodies Ltd. in their 13F filings, up 1 from Q3 2024. 1 opened new positions and 0 sold out. The largest holders were Ingalls & Snyder LLC ($643K), Renaissance Technologies ($32K) and Cibc World Market Inc. ($17K). One famous investor held it Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Immunoprecise Antibodies Ltd.
- CUSIP
- 45257F200
- Latest filing quarter
- Q3 2025
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $9K |
| Exits | 0 | $0 |
All 13F filers, Q3 2024 → Q4 2024: 48,899 shares bought and 38,940 shares sold, net +9,959 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 19 holders
| Ingalls & Snyder LLC | 0.03% | Add +0.2% | 1,561,332 | $643K |
| Renaissance Technologies | 0.00% | Add +29.7% | 78,200 | $32K |
| Cibc World Market Inc. | 0.00% | No change | 41,200 | $17K |
| Northern Trust Corp. | 0.00% | Reduce -19.0% | 41,106 | $17K |
| Bank of Montreal | 0.00% | Reduce -38.9% | 35,307 | $15K |
| Gradient Capital Advisors, LLC | 0.00% | No change | 26,808 | $11K |
| Federation des caisses Desjardins du Quebec | 0.00% | No change | 26,273 | $11K |
| XTX Topco Ltd | 0.00% | Add +49.3% | 23,399 | $10K |
| Virtu Financial LLC | 0.00% | New | 20,759 | $9K |
| Rathbones Group PLC | 0.00% | No change | 14,000 | $6K |
| Morgan Stanley | 0.00% | No change | 12,533 | $5K |
| Geode Capital Management, LLC | 0.00% | Reduce -39.0% | 10,668 | $4K |
| Mariner, LLC | 0.00% | No change | 10,000 | $4K |
| Bank of America Corp. | 0.00% | No change | 2,000 | $822 |
| National Bank of Canada | 0.00% | No change | 1,671 | $688 |
| West Paces Advisors Inc. | 0.00% | No change | 1,665 | $685 |
| Group One Trading LLC | 0.00% | No change | 61 | $25 |
| Citigroup Inc. | 0.00% | No change | 7 | $3 |
| Simplex Trading, LLC | 0.00% | Add +76.0% | 176 | $0 |
"% of holder's portfolio" is IMMUNOPRECISE ANTIBODIES LTD's weight in each manager's 13F, not the share of Immunoprecise Antibodies Ltd. the manager owns.